Welcome and Keynote Lecture: Immunotherapy—Lessons Learned From Melanoma for Application to GI Malignancies

Siwen Hu-Lieskovan, MD, PhD
University of California, Los Angeles Medical Center

Conclusions:

• lmmunotherapy for cancer has the potential to provide durable benefit to a wide array of patients.

• Rational combination strategies to improve efficacy will rely on

-- • A clear understanding of the heterogeneity of intrinsic & extrinsic immune resistant mechanisms that exists in each pt.

-- • Successful development of predictive biomarkers

-- • Collaborative effort of academia, industry and regulatory authorities